Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (9r,13s)-13-(4-(5-chloro-2-(4-chlorotriazol-1-yl)phenyl)-6-oxopyrimidin-1-yl)-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo(12.3.1.02,6)octadeca-1(18),2(6),4,14,16-pentaen-8-one
2. Bms-986177
3. Jnj-70033093
1. 1802425-99-5
2. Milvexian [usan]
3. Bms-986177
4. Jnj-70033093
5. 0w79ndq608
6. Milvexian (usan)
7. Bms 986177
8. (5r,9s)-9-(4-(5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl)-6-oxopyrimidin-1(6h)-yl)-21-(difluoromethyl)-5-methyl-21h-3-aza-1(4,2)-pyridina-2(5,4)-pyrazolacyclonaphan-4-one
9. (9r,13s)-13-[4-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-6-oxopyrimidin-1-yl]-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
10. Milvexian [inn]
11. Unii-0w79ndq608
12. Chembl4112929
13. Schembl16982989
14. Gtpl11754
15. Ex-a6455
16. Bms986177
17. Who 11401
18. Jnj70033093
19. Compound 17 [pmid: 34494428]
20. Ac-36903
21. Hy-125856
22. Cs-0101887
23. D11802
24. (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxopyrimidin-1(6h)-yl}-1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-15,11-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one
25. (9r,13s)-13-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1,6-dihydropyrimidin-1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15-tetraazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
26. 11,15-metheno-15h-pyrazolo(4,3-b)(1,7)diazacyclotetradecin-5(6h)-one, 10-(4-(5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl)-6-oxo-1(6h)-pyrimidinyl)-1-(difluoromethyl)-1,4,7,8,9,10-hexahydro-6-methyl-, (6r,10s)-
27. 11,15-metheno-15h-pyrazolo(4,3-b)(1,7)diazacyclotetradecin-5(6h)-one, 10-(4-(5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl)-6-oxo-1(6h)-pyrimidinyl)-1-(difluoromethyl)-1,4,7,8,9,10-hexahydro-6-methyl-, (6r,10s)-2
28. Bms-986177; (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxopyrimidin-1(6h)-yl}-1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-15,11-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one
29. Yxg
| Molecular Weight | 626.4 g/mol |
|---|---|
| Molecular Formula | C28H23Cl2F2N9O2 |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | 625.1319827 g/mol |
| Monoisotopic Mass | 625.1319827 g/mol |
| Topological Polar Surface Area | 123 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 1100 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Milvexian manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milvexian, including repackagers and relabelers. The FDA regulates Milvexian manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milvexian API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Milvexian supplier is an individual or a company that provides Milvexian active pharmaceutical ingredient (API) or Milvexian finished formulations upon request. The Milvexian suppliers may include Milvexian API manufacturers, exporters, distributors and traders.
Milvexian Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milvexian GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milvexian GMP manufacturer or Milvexian GMP API supplier for your needs.
A Milvexian CoA (Certificate of Analysis) is a formal document that attests to Milvexian's compliance with Milvexian specifications and serves as a tool for batch-level quality control.
Milvexian CoA mostly includes findings from lab analyses of a specific batch. For each Milvexian CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milvexian may be tested according to a variety of international standards, such as European Pharmacopoeia (Milvexian EP), Milvexian JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milvexian USP).
LOOKING FOR A SUPPLIER?
